Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJohnson Matthey Regulatory News (JMAT)

Share Price Information for Johnson Matthey (JMAT)

Share Price is delayed by 15 minutes
Get Live Data
2,080.00    -62.00 (-2.89%)
Bid:
2,066.00
Ask:
2,070.00
Spread: 4.00 (0.194%)
Market Cap: £3.48b
JMAT Live PriceLast checked at - London Stock Exchange

Intraday Johnson Matthey Share Chart

Directorate Changes

26 Jul 2017 10:02

RNS Number : 1398M
Johnson Matthey PLC
26 July 2017
 

Johnson Matthey Plc Directorate Changes

 

The board of Johnson Matthey Plc is pleased to announce the appointment of John O'Higgins, as a non-executive director of the company. He will join the board with effect from 16th November 2017.

 

John is currently Chief Executive of Spectris plc, a leading supplier of productivity-enhancing instrumentation and controls. He joined the board of Spectris plc as Chief Executive in January 2006. Prior to this John worked for Honeywell in a number of management roles, including as president of automation and control solutions, Asia Pacific. He began his career as a design engineer at Daimler-Benz in Stuttgart.

 

John will be replacing Colin Matthews CBE FREng, a non-executive director and Chairman of the Remuneration Committee. Colin is standing down from his role with effect from 15th November 2017 after five years on the board, having been appointed a non-executive director in October 2012 and Chairman of the Remuneration Committee in July 2016.

 

Chris Mottershead, a non-executive director, will be appointed as Chairman of the Remuneration Committee from 16th November 2017.

 

Tim Stevenson OBE, Chairman, commented:

 

"On behalf of all of us on the board I would like to thank Colin for his significant contributions during his time as a non-executive director.

 

I am very pleased to welcome John to the board and we look forward to working with him and benefiting from his extensive business and industrial experience".

 

 

Disclosures required pursuant to Rule 9.6.13 of the Listing Rules of the Financial Conduct Authority (including directorships held in other publicly quoted companies at any time in the previous five years)

 

John was appointed as a director of Spectris plc in January 2006, a company listed on the London Stock Exchange.

 

From September 2010 to April 2015, John was a non-executive director of Exide Technologies, Inc, a company listed on the Nasdaq stock exchange.

 

Other than as stated in this announcement, there are no other disclosures required pursuant to Rule 9.6.13 of the Listing Rules of the Financial Conduct Authority.

 

Enquiries:

Sally Jones

Director of Corporate Communications

020 7269 8407

Andrew Grant/David Allchurch

Tulchan Communications

020 7353 4200

www.matthey.com

26th July 2017

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAPGUGUMUPMUBQ
Date   Source Headline
15th Aug 20242:35 pmRNSHolding(s) in Company
15th Aug 20242:25 pmRNSDirector/PDMR Shareholding
15th Aug 20247:00 amRNSTransaction in Own Shares
14th Aug 20242:47 pmRNSHolding(s) in Company
14th Aug 20247:00 amRNSTransaction in Own Shares
13th Aug 20247:00 amRNSTransaction in Own Shares
12th Aug 202412:58 pmRNSDirector/PDMR Shareholding
12th Aug 20247:00 amRNSTransaction in Own Shares
9th Aug 20244:01 pmRNSHolding(s) in Company
9th Aug 20247:00 amRNSTransaction in Own Shares
8th Aug 20247:00 amRNSTransaction in Own Shares
7th Aug 20249:16 amRNSHolding(s) in Company
7th Aug 20247:00 amRNSTransaction in Own Shares
6th Aug 202410:55 amRNSHolding(s) in Company
6th Aug 20247:00 amRNSTransaction in Own Shares
5th Aug 20244:18 pmRNSDirector/PDMR Shareholding
5th Aug 20247:00 amRNSTransaction in Own Shares
2nd Aug 20247:00 amRNSTransaction in Own Shares
1st Aug 20247:00 amRNSTransaction in Own Shares
1st Aug 20247:00 amRNSTotal Voting Rights
31st Jul 20244:35 pmRNSHolding(s) in Company
31st Jul 20247:00 amRNSTransaction in Own Shares
30th Jul 20247:00 amRNSTransaction in Own Shares
29th Jul 20247:00 amRNSTransaction in Own Shares
26th Jul 20247:00 amRNSTransaction in Own Shares
25th Jul 20247:00 amRNSTransaction in Own Shares
24th Jul 20247:00 amRNSTransaction in Own Shares
23rd Jul 20247:00 amRNSTransaction in Own Shares
22nd Jul 20247:00 amRNSTransaction in Own Shares
19th Jul 202412:53 pmRNSHolding(s) in Company
19th Jul 202410:36 amRNSTransaction in Own Shares
18th Jul 20244:25 pmRNSDirector/PDMR Shareholding
18th Jul 202412:46 pmRNSResult of AGM
18th Jul 20247:00 amRNSTransaction in Own Shares
17th Jul 20247:00 amRNSTransaction in Own Shares
16th Jul 20247:00 amRNSTransaction in Own Shares
15th Jul 20247:00 amRNSTransaction in Own Shares
12th Jul 20247:00 amRNSTransaction in Own Shares
11th Jul 20247:00 amRNSTransaction in Own Shares
10th Jul 20247:00 amRNSTransaction in Own Shares
9th Jul 202410:34 amRNSHolding(s) in Company
9th Jul 20247:00 amRNSTransaction in Own Shares
8th Jul 20247:00 amRNSTransaction in Own Shares
5th Jul 20247:00 amRNSTransaction in Own Shares
4th Jul 20245:06 pmRNSHolding(s) in Company
4th Jul 20247:00 amRNSTransaction in Own Shares
3rd Jul 20243:24 pmRNSHolding(s) in Company
3rd Jul 20247:00 amRNSShare buyback programme
2nd Jul 20243:04 pmRNSHolding(s) in Company
1st Jul 20242:38 pmRNSCompletion of Medical Device Components sale

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.